Results 161 to 170 of about 192,739 (195)
Chemistry &Biodiversity, EarlyView.ABSTRACT This study explores the phytochemical composition and biological potential of extracts from Achillea conferta leaves, specifically hydroethanolic extract (HE), total flavonoid extract (TFE), and glycoside flavonoid extract (GFE). Phytochemical screening of HE revealed significant concentrations of phenolic compounds, flavonoids, and tannins ...
Mhmood Shakoori Yaseen +3 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT We report the case of a 3‐year‐old asymptomatic girl (12 kg, 96 cm) who was diagnosed with a large iatrogenic left ventricular pseudoaneurysm (LVP) on follow‐up ultrasound, 14 months after apical muscular ventricular septal defect (VSD) closure with a 10 mm Amplatzer Muscular VSD occluder (Abbott, USA) due to device erosion.
Raymond N. Haddad +3 more
wiley +1 more source
Steerable Delivery Sheath for Optimized LAA Closure: First Experience and Procedural Outcomes
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background The new Amplatzer Steerable Delivery Sheath is a delivery system designed to improve ease‐of‐use and procedural results of left atrial appendage closure (LAAC). We aimed to compare procedural results after switching our LAAC program at a tertiary care center with the Amulet device to the Steerable Delivery Sheath, with a control ...
Matthias Mezger +4 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Transcatheter pulmonary valve replacement (TPVR) has emerged as a valuable treatment for severe pulmonary regurgitation (PR). The Salus valve (Balance Medical Technology Co. Ltd., Beijing, China) represents a novel self‐expanding valve stent designed for deployment through a transthoracic approach with a small subxiphoid incision ...
Ziqin Zhou +6 more
wiley +1 more source
Catheterization and Cardiovascular Interventions, EarlyView.ABSTRACT Background Little is known about the clinical and hemodynamic outcome of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR) for failed Trifecta surgical aortic bioprotheses. Aims We aimed to compare outcomes of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR into failed TrifectaTM vs.
Matthias Raschpichler +9 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Biomedizinische Technik/Biomedical Engineering, 2013
Cardiac valvular pathologies are often caused by rheumatic fever in young adults, atherosclerosis in elderly patients, or by congenital malformation of the heart in children, in effect affecting almost all population ages. Almost 300,000 heart valve operations are performed worldwide annually.
Anatol Ciubotaru +5 more
openaire +3 more sources
Cardiac valvular pathologies are often caused by rheumatic fever in young adults, atherosclerosis in elderly patients, or by congenital malformation of the heart in children, in effect affecting almost all population ages. Almost 300,000 heart valve operations are performed worldwide annually.
Anatol Ciubotaru +5 more
openaire +3 more sources
Scottish Medical Journal, 1987
A patient having had both aortic and mitral valves replaced complained of triggering shop security alarms, attributing the problem to the prosthetic valves. It was demonstrated that the valves were not the cause of the problem and the source identified.
Elliott At, Bain Wh
openaire +3 more sources
A patient having had both aortic and mitral valves replaced complained of triggering shop security alarms, attributing the problem to the prosthetic valves. It was demonstrated that the valves were not the cause of the problem and the source identified.
Elliott At, Bain Wh
openaire +3 more sources
Patents and Heart Valve Surgery – III: Percutaneous Heart Valves
Recent Patents on Cardiovascular Drug Discovery, 2014Advancements in technology for the treatment of valvularcardiac diseases seek to provide solutions for high risk patients in the form of percutaneous valve insertion for patients with complicated valvular disease not amenable to more traditional options.
F.H. Cheema +5 more
openaire +4 more sources
Annual Review of Medicine, 1990 This overview of heart valve prostheses is based on a current review of clinical reports and focuses on the major complications that characterize long-term valve performance: thromboembolism, thrombosis, anti-coagulant-related bleeding, and structural failure.
Shahbudin H. Rahimtoola +1 more
openaire +2 more sources
Cardiology Clinics, 2011
The first prosthetic valve was implanted by Hufnagel in 1952 in a patient with aortic insufficiency. Since then, prosthetic valves have evolved into various mechanical and bioprosthetic shapes and sizes. Despite the excitement surrounding the current development of prosthetic heart valves, surgically implanted valves remain the mainstay of current ...
C. Ryan Longnecker, Michael J. Lim
openaire +3 more sources
The first prosthetic valve was implanted by Hufnagel in 1952 in a patient with aortic insufficiency. Since then, prosthetic valves have evolved into various mechanical and bioprosthetic shapes and sizes. Despite the excitement surrounding the current development of prosthetic heart valves, surgically implanted valves remain the mainstay of current ...
C. Ryan Longnecker, Michael J. Lim
openaire +3 more sources